Management of cancer-associated thrombosis with thrombocytopenia: Impact of the ISTH guidance statement.
Nicole HeldBenjamin JungLisa Baumann KreuzigerPublished in: Research and practice in thrombosis and haemostasis (2022)
The ISTH guidance on management of cancer-associated thrombosis in patients with thrombocytopenia was successfully implemented in an academic medical center. There was no significant difference in bleeding or recurrent thrombosis outcomes after adjusting for acuity of VTE.